Closed triple therapy
Showing 1 - 25 of >10,000
Helicobacter Pylori Infection Trial in Seoul (Tegoprazan 50 mg Triple Therapy, Tegoprazan 100 mg Triple Therapy, Lansoprazole
Recruiting
- Helicobacter Pylori Infection
- Tegoprazan 50 mg Triple Therapy
- +2 more
-
Seoul, Korea, Republic ofChung-Ang University Hosptial
Jul 3, 2023
Pulmonary Wedge Resection Trial in Taizhou (fixed with the triple-buffer system, fixed using the conventional lifting platform
Completed
- Pulmonary Wedge Resection
- fixed with the triple-buffer system
- fixed using the conventional lifting platform method
-
Taizhou, Zhejiang, ChinaTaizhou Hospital of Zhejiang Province affiliated to Wenzhou Medi
Oct 27, 2022
Pregnancy Related Trial (Uterine layers closed, Suture Type, Endometrium)
Not yet recruiting
- Pregnancy Related
- Uterine layers closed
- +2 more
- (no location specified)
Feb 28, 2023
Surgical Wound Infection Trial in Bern (Closed incision negative pressure wound therapy, Standard dressing)
Not yet recruiting
- Surgical Wound Infection
- Closed incision negative pressure wound therapy
- Standard dressing
-
Bern, SwitzerlandInselspital, Bern University Hospital
Oct 6, 2023
Alzheimer, Mild Cognitive Impairment Trial in Charlestown (tACS device)
Not yet recruiting
- Alzheimer Disease
- Mild Cognitive Impairment
- tACS device
-
Charlestown, MassachusettsMassachusetts General Hospital
Jun 6, 2023
Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)
Not yet recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Antivascular therapy
- Chemotherapy
- (no location specified)
Jun 11, 2023
Helicobacter Pylori Infection Trial in Ljubljana (Bismuth Subcitrate)
Recruiting
- Helicobacter Pylori Infection
- Bismuth Subcitrate
-
Ljubljana, SloveniaMatjaž Homan
Nov 19, 2023
Helicobacter Pylori Infection Trial in Shanghai (Vonoprazan, Amoxicillin, Metronidazole, Bismuth Potassium Citrate)
Not yet recruiting
- Helicobacter Pylori Infection
- Vonoprazan
- +3 more
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Feb 3, 2023
Helicobacter Pylori Infection, Helicobacter Pylori Eradication Trial in Dhaka (group A : Amoxicillin Esomeprazole HDDT, group-B
Recruiting
- Helicobacter Pylori Infection
- Helicobacter Pylori Eradication
- group A : Amoxicillin Esomeprazole HDDT
- group-B : Levofloxacin triple therapy
-
Dhaka, BangladeshBangabandhu sheikh mujib medical university
Oct 12, 2023
Triple Negative Breast Cancer Trial (Sacituzumab govitecan, Pembrolizumab)
Not yet recruiting
- Triple Negative Breast Cancer
- Sacituzumab govitecan
- Pembrolizumab
- (no location specified)
Oct 5, 2023
Vital Pulp Treatment in Mature Permanent Teeth With Irreversible Pulpitis Trial in Cairo (Total pulpotomy with I-prf mixed with
Recruiting
- Vital Pulp Treatment in Mature Permanent Teeth With Irreversible Pulpitis
- Total pulpotomy with I-prf mixed with Nano-bioactive glass
-
Cairo, EgyptNoor Mohammed Kamal Eldeen
May 24, 2023
Postoperative Nausea and Vomiting, Gynecologic Surgical Procedures, Laparoscopy Trial (fosaprepitant, normal saline)
Not yet recruiting
- Postoperative Nausea and Vomiting
- +2 more
- fosaprepitant
- normal saline
- (no location specified)
Mar 16, 2023
Time in Range Trial in Cairo (Dipeptidyl peptidase-4 inhibitors)
Completed
- Time in Range
- Dipeptidyl peptidase-4 inhibitors
-
Cairo, EgyptNancy Elbarbary
Aug 26, 2023
TNBC - Triple-Negative Breast Cancer Trial (Camrelizumab Plus Chemotherapy and Famitinib, Camrelizumab Plus Chemotherapy)
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- Camrelizumab Plus Chemotherapy and Famitinib
- Camrelizumab Plus Chemotherapy
- (no location specified)
Aug 17, 2023
Type 1 Diabetic Nephropathy Trial in Cairo (oral sitagliptin supplementation)
Completed
- Type 1 Diabetic Nephropathy
- oral sitagliptin supplementation
-
Cairo, EgyptNancy Elbarbary
Nov 2, 2023
Helicobacter Pylori Infection Trial in New York (Amoxicillin, Omeprazole, Clarithromycin)
Completed
- Helicobacter Pylori Infection
- Amoxicillin
- +2 more
-
New York, New YorkMount Sinai Union Square Division of Digestive Diseases
Jan 6, 2023
Copd, Adherence, Medication Trial (single-inhaler triple therapy (Trimbow), E-health application: Curavista app & FindAir
Not yet recruiting
- Copd
- Adherence, Medication
- single-inhaler triple therapy (Trimbow)
- +2 more
- (no location specified)
Aug 8, 2022
Triple Negative Breast Tumors Trial (Pembrolizumab injection, Capecitabine tablets, Local radiotherapy)
Not yet recruiting
- Triple Negative Breast Neoplasms
- Pembrolizumab injection
- +2 more
- (no location specified)
Jul 25, 2023
Perioperative Hyperglycaemia, Insulin Therapy, Elective Surgery Trial in Basel, Bern (CamAPS HX, Standard insulin therapy)
Recruiting
- Perioperative Hyperglycaemia
- +9 more
- CamAPS HX
- Standard insulin therapy
-
Basel, Switzerland
- +1 more
Dec 6, 2022
Helicobacter Pylori Infection Trial in Zagazig (Black Seed Oil Cap/Tab, Vonoprazan, Amoxicillin and Clarithromycin)
Not yet recruiting
- Helicobacter Pylori Infection
- Black Seed Oil Cap/Tab
- Vonoprazan, Amoxicillin and Clarithromycin
-
Zagazig, EgyptGIT department zagazig university hospital
Jul 14, 2023
Surgical Site Infection, Surgical Wound, Surgical Wound Infection Trial in Penafiel (Incisional negative pressure wound therapy,
Recruiting
- Surgical Site Infection
- +6 more
- Incisional negative pressure wound therapy
- Control group - standard wound dressing
-
Penafiel, Porto, PortugalCentro Hospitalar do Tâmega e Sousa
Feb 8, 2023
TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- (no location specified)
May 8, 2023
Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)
Active, not recruiting
- Metastatic Non-small Cell Lung Cancer
- Metastatic Triple-negative Breast Cancer
- ADV/HSV-tk
- +3 more
-
Houston, TexasHouston Methodist Cancer Center
Dec 28, 2022
Breast Cancer Trial in Beijing (Pembrolizumab, Paclitaxel, Epirubicin)
Recruiting
- Breast Cancer
- Pembrolizumab
- +3 more
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Dec 28, 2022
Helicobacter Pylori Infection Trial in Santiago (Optimized bismuth quadruple therapy, Control)
Recruiting
- Helicobacter Pylori Infection
- Optimized bismuth quadruple therapy
- Control
-
Santiago, Metropolitana, Chile
- +1 more
Dec 21, 2022